Michael T. Cullen
CIK 1652996 · Executive Chairman · last filed 2023-03-29
Michael T. Cullen is an Executive Chairman who has filed 17 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for PBLA, was dated Mar 29, 2023. Current disclosed insider exposure totals $6.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.5K
2
17
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PBLA | Executive Chairman | 586,387 | $0.01 | $6.5K | $0 | 4 | 2023-03-29 |
| Panbela Therapeutics, Inc. (SNBP) Delisted | Exec. Chairman, Pres. & CEO | 412,571 | — | — | $0 | 2 | 2020-09-01 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-29 | PBLA | Grant (A) | — | $0 | EDGAR |
| 2022-10-06 | PBLA | Buy (P) | +165,000 | $0 | EDGAR |
| 2021-05-27 | PBLA | Grant (A) | +4,316 | $0 | EDGAR |
| 2021-04-01 | PBLA | Grant (A) | — | $0 | EDGAR |
| 2020-09-01 | Panbela Therapeutics, Inc. (SNBP) Delisted | Buy (P) | +10,000 | $0 | EDGAR |
| 2020-09-01 | Panbela Therapeutics, Inc. (SNBP) Delisted | Buy (P) | +10,000 | $0 | EDGAR |
| 2020-06-26 | — | Grant (A) | — | $0 | |
| 2020-05-27 | — | Buy (P) | +10,000 | $0 | |
| 2019-09-26 | — | Grant (A) | — | $0 | |
| 2019-09-04 | — | Buy (P) | +30,000 | $0 |